Search the Newsreel

Biohaven Adds Technology Investor John Yetimoglu to Board as AI Strategy Advances

Biohaven Ltd. (NYSE: BHVN) has appointed technology investor John Yetimoglu to its Board of Directors to bolster its artificial intelligence and computational technologies strategy in drug discovery and development. Yetimoglu, founder of Infinitum and an early investor in Groq, brings extensive experience in emerging …

Cavendish sticks with 42p target as Pathos shares recover ground

Price to earnings forward of Cavendish plc – LSE:CAV

Number of shareholders of Cavendish plc – LSE:CAV

BVN Crosses Above Key Moving Average Level

In trading on Tuesday, shares of Compania de Minas Buenaventura S.A. (Symbol: BVN) crossed above their 200 day moving average of $31.76, changing hands as high as $32.21 per share. Compania de Minas Buenaventura S.A. shares are currently trading up about 5.7% on the …

San Gabriel: Buenaventura comenzó a registrar volúmenes de ventas en el segundo trimestre

Compañía de Minas Buenaventura's San Gabriel mine in Moquegua began registering sales volumes in Q2 2026, despite ramp-up challenges with tailings management. The mine reported an initial gold sales cost (CAS) of US$5,640/oz, which is not yet representative of long-term costs due to current …

Whitehaven Coal (ASX:WHC) Shares Edge Higher as ASX Investors Track Coal Market Recovery, Production Outlook and Growth Strategy

AvenuesAI Q1 Results: Earnings call scheduled for August 11, 2026

How Stronger First-Half 2026 Profitability Will Impact Compañía de Minas Buenaventura (BVN) Investors

Antamina, Buenaventura y Chinalco concentran el 33.6% de la producción nacional de plata a mayo

In May, Peru's national silver production decreased by 11.3% compared to the previous year, totaling 278,862 kilograms fine, largely due to lower output from Compañía Minera Ares S.A.C. and Volcan Compañía Minera S.A.A. Compañía Minera Antamina S.A., Compañía de Minas Buenaventura S.A.A., and Minera …

Biohaven (BHVN) Expected to Release Quarterly Earnings on Monday

Defilade Capital Management L.P. Buys Shares of 315,944 Biohaven Ltd. $BHVN

San Gabriel debuta con ventas y ya suma al oro de Buenaventura en Perú

Compañía de Minas Buenaventura, Perú's largest precious metals company, saw its gold production reach 30,543 ounces in Q2 2026 from direct operations, with the San Gabriel mine contributing to an overall 12% year-on-year increase despite initial processing difficulties. The company also significantly increased silver …

Compania De Minas Buenaventura SAA (BVN) (Q2 2026) Earnings Call Highlights: Record Revenue and ...

This article first appeared on GuruFocus. Total Revenues: $529 million, a 43% increase year over year. EBITDA from Direct Operations: $277 million, up 113% year over year. EBITDA Margin: Expanded from 35% to 52%. Net Income: $261 million, a 165% increase year over year. …

Biohaven Ltd. $BHVN Shares Bought by Janus Henderson Group PLC

Buenaventura casi triplicó sus utilidades en el segundo trimestre, ¿qué impulsó sus resultados?

Compañía de Minas Buenaventura saw its net profit almost triple in the second quarter of 2026, reaching US$260.8 million, driven by favorable international prices for gold, silver, and copper. The mining company's revenues grew by 57% to US$580.8 million, with EBITDA from direct operations …

Biohaven Pharma earnings on deck amid epilepsy trial scrutiny

Biohaven Pharmaceutical Holding Co. is set to report second-quarter results, with analysts anticipating a narrower loss per share. Investors will be closely watching for updates on the company's cash runway and the timeline for pivotal Phase 2/3 epilepsy trial results for its experimental drug, …

Compania de Minas Buenaventura SAA ADR (BVN) reaches earnings week with momentum split

The precious-metals miner is due to report July 30, with the consensus estimate at $0.99 for the quarter ended June 30.

Compañía de Minas Buenaventura S.A.A. (BVN) Releases Q2 2026 Earnings: Revenue Up 43.2% YoY

Buenaventura: Q2 Earnings Snapshot

Buenaventura Announces Second Quarter 2026 Results

LIMA, Peru, July 31, 2026--(BUSINESS WIRE)--Compañia de Minas Buenaventura S.A.A. ("Buenaventura" or "the Company") (NYSE: BVN; Lima Stock Exchange: BUE.LM), Peru's largest publicly-traded precious metals mining company, today announced results for the second quarter (2Q26) ended June 30, 2026. All figures have been prepared …

Biohaven Insiders Added US$33.1m Of Stock To Their Holdings

This article discusses recent insider purchases at Biohaven Pharmaceutical Holding Company. Insiders bought US$33.1 million worth of stock, suggesting confidence in the company's future despite a recent share price decline. The purchases come after the company's acquisition of a migraine drug by Pfizer, which …

Minas Buenaventura Number of Employees 2026 | Employee Count & Headcount Data

This article provides an in-depth look at Minas Buenaventura's workforce data as of March 2026, sourced from Revelio Labs. It details the company's employee count, growth rates, regional distribution, departmental breakdown, salary information, hiring trends, and employee sentiment. Minas Buenaventura, an Energy and Resources …

Biohaven Ltd (BHVN) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Biohaven Ltd (BHVN), covering operating, investing, and financing activities. It also includes frequently asked questions explaining different types of cash flow and Biohaven's specific cash flow figures for operating, investing, financing, and …

Buenaventura Mining (BVN) Earnings Date and Reports 2026 $BVN

Compañía de Minas BuenaventuraA (NYSE:BVN) On Updated 2026 Guidance And The Undervalued Narrative

Biohaven (BHVN) Following Its Court Win Still Looks Cheap Against Fair Value

Biohaven (BHVN) recently won a federal jury case related to misappropriated trade secrets, yet its share price has seen a short-term decline despite strong 90-day and year-to-date gains. A Discounted Cash Flow (DCF) model estimates Biohaven's fair value at $61.24, significantly higher than its …

Biohaven and Yale win $4M verdict in trade secret case

A federal jury awarded Biohaven Ltd. and Yale University $4 million in a trade secret misappropriation case against Avilar Therapeutics, Inc. and RA Capital Management GP, LLC. The jury found that Avilar and RA Capital willfully and maliciously misappropriated a Yale trade secret related …

Yale, Biohaven Win $4M In Biotech Trade Secret Trial

A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million in a biotech trade secret trial. The verdict found that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with Avilar Therapeutics, misappropriated a Yale-developed trade secret …

Yale, Biohaven Win $4 Million Verdict Over Drug-Development Tech

Yale University and Biohaven Therapeutics Ltd. were jointly awarded $4 million in a Delaware trial. The verdict found Avilar Therapeutics Inc. and RA Capital Management GP LLC liable for misappropriating Yale's "MODA" drug-development trade secret and for breaching a confidentiality agreement. The jury specifically …

Biohaven Awarded $1 Million Over Alleged Trade Secret Violations by Avilar Therapeutics, RA Capital Management

Biohaven (BHVN) said Monday that a federal jury has awarded it $1 million in damages over an alleged PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. …

Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million

A federal jury found Avilar Therapeutics and RA Capital Management GP, LLC guilty of willfully and maliciously misappropriating a trade secret developed at Yale University related to its "MODA" targeted protein degradation platform. RA Capital was also found to have breached a confidentiality agreement …

How Biohaven’s (BHVN) Trade Secret Verdict Shapes Its Intellectual Property Defense Strategy

Biohaven recently won a US$1,000,000 trade secret lawsuit, reinforcing its commitment to protecting intellectual property. While this win strengthens the narrative around IP quality, it doesn't change the company's core investment risks, which include clinical outcomes, funding needs, and potential shareholder dilution. Biohaven remains …

Biohaven Ltd (BHVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Biohaven Ltd (BHVN) stock, focusing on various indicators and moving averages. It presents a summary of buy, neutral, and sell signals derived from tools such as MACD, RSI, and different moving average periods. The analysis concludes with …

BHVN|Biohaven Ltd|Price:14.320|Chg%:-0.320

This article provides a detailed financial overview of Biohaven Ltd (BHVN), including key financial indicators, income statements, balance sheets, and cash flow statements for various quarters and fiscal years. It highlights the company's latest earnings, revenue forecasts, and analyst ratings, presenting a comprehensive data …

Buenaventura (BVN) Stock May Trade At A Discount Following Q2 Results